MedTrace Logo

MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome

NCT07185139 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-09-22

No results posted yet for this study

Summary

This study is aSingle-center, multiple-dosing, prospective, nonrandom, single-arm trial.

Conditions

  • Sjögren's Syndrome

Interventions

DRUG

MSCohi-O Lenses

Each subject will wear MSCohi-O Lenses for 12 hours a day, totally 14 wearings.

Sponsors & Collaborators

  • Guangdong ProCapZoom Biosciences Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-12
Primary Completion
2026-08-30
Completion
2026-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07185139 on ClinicalTrials.gov